ReviewOncotarget2017
A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer.
Jose Mauricio Mota et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
41 papers cite it
this paperpooled ittrialcites it